Incidence of childhood and adolescent melanoma in the United States: 1973-2009
- PMID: 23589817
- PMCID: PMC3639457
- DOI: 10.1542/peds.2012-2520
Incidence of childhood and adolescent melanoma in the United States: 1973-2009
Abstract
Objective: Childhood and adolescent melanoma is rare but has been increasing. To gain insight into possible reasons underlying this observation, we analyzed trends in melanoma incidence diagnosed between the ages of 0 and 19 years among US whites by gender, stage, age at diagnosis, and primary site. We also investigated incidence trends by UV-B exposure levels.
Methods: By using Surveillance, Epidemiology, and End Results (SEER) program data (1973-2009), we calculated age-adjusted incidence rates (IRs), annual percent changes, and 95% confidence intervals for each category of interest. Incidence trends were also evaluated by using joinpoint and local regression models. SEER registries were categorized with respect to low or high UV-B radiation exposure.
Results: From 1973 through 2009, 1230 children of white race were diagnosed with malignant melanoma. Overall, pediatric melanoma increased by an average of 2% per year (95% confidence interval, 1.4%-2.7%). Girls, 15- to 19-year-olds, and individuals with low UV-B exposure had significantly higher IRs than boys, younger children, and those living in SEER registries categorized as high UV-B. Over the study period, boys experienced increased IRs for melanoma on the face and trunk, and females on the lower limbs and hip. The only decreased incidence trend we observed was among 15- to 19-year-olds in the high UV-B exposure group from 1985 through 2009. Local regression curves indicated similar patterns.
Conclusions: These results may help elucidate possible risk factors for adolescent melanoma, but additional individual-level studies will be necessary to determine the reasons for increasing incidence trends.
Keywords: SEER; UV; adolescence; cancer; childhood; epidemiology; incidence; melanoma; trends.
Figures
![FIGURE 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3639457/bin/peds.2012-2520fig01.gif)
![FIGURE 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3639457/bin/peds.2012-2520fig02.gif)
Similar articles
-
Malignant melanoma incidence among children and adolescents in Texas and SEER 13, 1995-2013.Pediatr Blood Cancer. 2019 Jun;66(6):e27648. doi: 10.1002/pbc.27648. Epub 2019 Feb 7. Pediatr Blood Cancer. 2019. PMID: 30729662 Free PMC article.
-
Age-Specific Incidence of Melanoma in the United States.JAMA Dermatol. 2020 Jan 1;156(1):57-64. doi: 10.1001/jamadermatol.2019.3353. JAMA Dermatol. 2020. PMID: 31721989 Free PMC article.
-
Joinpoint regression analysis of recent trends in desmoplastic malignant melanoma incidence and mortality: 15-year multicentre retrospective study.Arch Dermatol Res. 2024 May 25;316(6):273. doi: 10.1007/s00403-024-02928-y. Arch Dermatol Res. 2024. PMID: 38796649
-
Cancers with increasing incidence trends in the United States: 1999 through 2008.CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28. doi: 10.3322/caac.20141. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22281605 Review.
-
Melanoma incidence trends.Dermatol Clin. 2002 Oct;20(4):589-95, vii. doi: 10.1016/s0733-8635(02)00037-2. Dermatol Clin. 2002. PMID: 12380045 Review.
Cited by
-
Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.Pediatr Surg Int. 2024 Mar 5;40(1):68. doi: 10.1007/s00383-024-05646-8. Pediatr Surg Int. 2024. PMID: 38441654 Free PMC article.
-
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study.Dermatol Pract Concept. 2024 Jan 1;14(1):e2024026. doi: 10.5826/dpc.1401a26. Dermatol Pract Concept. 2024. PMID: 38364395 Free PMC article.
-
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.EJC Paediatr Oncol. 2023 Dec;2:100024. doi: 10.1016/j.ejcped.2023.100024. Epub 2023 Jul 20. EJC Paediatr Oncol. 2023. PMID: 37829670 Free PMC article.
-
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.J Natl Cancer Inst. 2023 Nov 8;115(11):1337-1354. doi: 10.1093/jnci/djad115. J Natl Cancer Inst. 2023. PMID: 37433078
-
The Family Lifestyles, Actions and Risk Education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors.Contemp Clin Trials. 2023 Aug;131:107276. doi: 10.1016/j.cct.2023.107276. Epub 2023 Jun 29. Contemp Clin Trials. 2023. PMID: 37393004
References
-
- Bleyer A, O’Leary M, Barr R, Ries LAG, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000 (NIH Pub. No. 06-5767). Bethesda, MD: National Cancer Institute; 2006
-
- Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112(2):416–432 - PubMed
-
- Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23(21):4735–4741 - PubMed
-
- Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol. 1994;130(8):1018–1021 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical